Quanterix Valuation Multiples

Quanterix Overview

About Quanterix

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Founded

2007

HQ

Employees

136

Website

quanterix.com

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $148M

EBITDA: ($36M)

EV

$74M

Valuation Multiples

Multiples.vc

Start free trial

Quanterix Financials

Quanterix reported last 12-month revenue of $148M and negative EBITDA of ($36M).

In the same LTM period, Quanterix generated $71M in gross profit, ($36M) in EBITDA losses, and had net loss of ($95M).

Quanterix P&L

In the most recent fiscal year, Quanterix reported revenue of $139M and EBITDA of ($45M).

Quanterix expects next 12-month revenue of XXX and NTM EBITDA of XXX

Quanterix Stock Performance

Quanterix has current market cap of $155M, and enterprise value of $74M.

Quanterix's stock price is $3.30.

Quanterix Valuation Multiples

Quanterix trades at 0.5x EV/Revenue multiple, and (2.0x) EV/EBITDA.

Quanterix Financial Valuation Multiples

As of April 11, 2026, Quanterix has market cap of $155M and EV of $74M.

Equity research analysts estimate Quanterix's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Quanterix has a P/E ratio of (1.6x).

Quanterix Margins & Growth Rates

Quanterix's revenue in the last 12 month grew by 19%.

Quanterix's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $1.3M for the same period.

Quanterix's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Quanterix's rule of X is 50% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Quanterix Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Quanterix M&A Activity

Quanterix acquired XXX companies to date.

Last acquisition by Quanterix was on XXXXXXXX, XXXXX. Quanterix acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Quanterix Investment Activity

Quanterix invested in XXX companies to date.

Quanterix made its latest investment on XXXXXXXX, XXXXX. Quanterix invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).